USA: Syngenta seeks approval for GM rice to help kidney patients
US agrochemicals company Syngenta is seeking regulatory approval for a genetically modified rice strain it says will improve the diet of patients undergoing kidney dialysis. The rice strain has been engineered to remove a protein which triggers allergic reactions. It has been designed for the Asian market, where dialysis patients cannot eat the local staple of rice because they suffer intolerance to its high protein content.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Price an underlying tension across European FMCG
- Danone's Q3 sales - what the analysts say
- Interview: UK trade body on Brexit's policy impact
- Interview: UK trade body on the impact of Brexit
- It won't just be Unilever to push for Brexit hikes
- Nestle lowers outlook on "softer environment"
- UK announces "action plan" to drive food exports
- Kraft Heinz: Innovation more important than ever
- Online snack seller Graze makes US retail debut
- Farmers' groups slam Danone over non-GMO stance
- The Big 15: Strategies and Priorities of Top Packaged Food Players in Comparison
- Omega-3 in Food and Beverage:Time for a Reboot?
- Global Food Packaging: Innovating for Greater Convenience and Quality Image
- Packaged Food: Quarterly Statement Q3 2016
- Constellation Brands, Inc. (STZ) - Financial and Strategic SWOT Analysis Review